120 related articles for article (PubMed ID: 1668326)
1. Characterization of a hepatitis A virus strain suitable for vaccine production.
Fineschi N; Cavalieri F; Garelick H; Prugnola A; Pellegrini V; Zuckerman AJ
J Hepatol; 1991; 13 Suppl 4():S146-51. PubMed ID: 1668326
[TBL] [Abstract][Full Text] [Related]
2. Antigenic and immunogenic properties of a hepatitis A virus capsid protein expressed in Escherichia coli.
Johnston JM; Harmon SA; Binn LN; Richards OC; Ehrenfeld E; Summers DF
J Infect Dis; 1988 Jun; 157(6):1203-11. PubMed ID: 2836522
[TBL] [Abstract][Full Text] [Related]
3. Immunologic priming with recombinant hepatitis A virus capsid proteins produced in Escherichia coli.
Powdrill TF; Johnston JM
J Virol; 1991 May; 65(5):2686-90. PubMed ID: 1850041
[TBL] [Abstract][Full Text] [Related]
4. Expression of hepatitis A virus cDNA in Escherichia coli: antigenic VP1 recombinant protein.
Ostermayr R; von der Helm K; Gauss-Müller V; Winnacker EL; Deinhardt F
J Virol; 1987 Nov; 61(11):3645-7. PubMed ID: 2822970
[TBL] [Abstract][Full Text] [Related]
5. Characterization of hepatitis A virus capsid proteins with antisera raised to recombinant antigens.
Ross BC; Anderson DA
J Virol Methods; 1991 May; 32(2-3):213-20. PubMed ID: 1651950
[TBL] [Abstract][Full Text] [Related]
6. Possible approaches to develop vaccines against hepatitis A.
D'Hondt E
Vaccine; 1992; 10 Suppl 1():S48-52. PubMed ID: 1335659
[TBL] [Abstract][Full Text] [Related]
7. Sequence analysis of a new hepatitis A virus naturally infecting cynomolgus macaques (Macaca fascicularis).
Nainan OV; Margolis HS; Robertson BH; Balayan M; Brinton MA
J Gen Virol; 1991 Jul; 72 ( Pt 7)():1685-9. PubMed ID: 1649902
[TBL] [Abstract][Full Text] [Related]
8. Exchange of the C-terminal part of VP3 from very virulent infectious bursal disease virus results in an attenuated virus with a unique antigenic structure.
Boot HJ; ter Huurne AA; Hoekman AJ; Pol JM; Gielkens AL; Peeters BP
J Virol; 2002 Oct; 76(20):10346-55. PubMed ID: 12239311
[TBL] [Abstract][Full Text] [Related]
9. Design, construction, and characterization of poliovirus antigen chimeras.
Evans DJ; Almond JW
Methods Enzymol; 1991; 203():386-400. PubMed ID: 1662331
[No Abstract] [Full Text] [Related]
10. Immunogenicity and antigenicity of chimeric picornaviruses which express hepatitis A virus (HAV) peptide sequences: evidence for a neutralization domain near the amino terminus of VP1 of HAV.
Lemon SM; Barclay W; Ferguson M; Murphy P; Jing L; Burke K; Wood D; Katrak K; Sangar D; Minor PD
Virology; 1992 May; 188(1):285-95. PubMed ID: 1314456
[TBL] [Abstract][Full Text] [Related]
11. Antibody response to nonstructural proteins of hepatitis A virus following infection.
Robertson BH; Jia XY; Tian H; Margolis HS; Summers DF; Ehrenfeld E
J Med Virol; 1993 May; 40(1):76-82. PubMed ID: 8390561
[TBL] [Abstract][Full Text] [Related]
12. Production of the antigen and the antibody of the JC virus major capsid protein VP1.
Chang D; Liou ZM; Ou WC; Wang KZ; Wang M; Fung CY; Tsai RT
J Virol Methods; 1996 May; 59(1-2):177-87. PubMed ID: 8793846
[TBL] [Abstract][Full Text] [Related]
13. Localization of a VP3 epitope of infectious bursal disease virus.
Jagadish MN; Azad AA
Virology; 1991 Oct; 184(2):805-7. PubMed ID: 1716030
[TBL] [Abstract][Full Text] [Related]
14. Detection of hepatitis A virus proteins in infected BS-C-1 cells.
Updike WS; Tesar M; Ehrenfeld E
Virology; 1991 Nov; 185(1):411-8. PubMed ID: 1656592
[TBL] [Abstract][Full Text] [Related]
15. Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot-and-mouth disease capsid protein epitopes on surface of hybrid virus particles.
Kit S; Kit M; DiMarchi RD; Little SP; Gale C
Arch Virol; 1991; 120(1-2):1-17. PubMed ID: 1718244
[TBL] [Abstract][Full Text] [Related]
16. Recombinant proteins VP1 and VP3 of hepatitis A virus prime for neutralizing response.
Gauss-Müller V; Zhou MQ; von der Helm K; Deinhardt F
J Med Virol; 1990 Aug; 31(4):277-83. PubMed ID: 2176673
[TBL] [Abstract][Full Text] [Related]
17. Antigenic and immunogenic properties of recombinant hepatitis A virus 14S and 70S subviral particles.
Stapleton JT; Raina V; Winokur PL; Walters K; Klinzman D; Rosen E; McLinden JH
J Virol; 1993 Feb; 67(2):1080-5. PubMed ID: 7678298
[TBL] [Abstract][Full Text] [Related]
18. Insertion of short hepatitis virus A amino acid sequences into poliovirus antigenic determinants results in viable progeny.
Sverdlov ED; Tsarev SA; Markova SV; Rostapshov VM; Azhikina TL; Chernov IP; Gorbalenya AE; Kolesnikova MS; Romanova LI; Teterina NL
FEBS Lett; 1989 Nov; 257(2):354-6. PubMed ID: 2479578
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the small open reading frame on genome segment A of infectious pancreatic necrosis virus.
Heppell J; Tarrab E; Berthiaume L; Lecomte J; Arella M
J Gen Virol; 1995 Aug; 76 ( Pt 8)():2091-6. PubMed ID: 7636493
[TBL] [Abstract][Full Text] [Related]
20. Antigenic and genetic variation in cytopathic hepatitis A virus variants arising during persistent infection: evidence for genetic recombination.
Lemon SM; Murphy PC; Shields PA; Ping LH; Feinstone SM; Cromeans T; Jansen RW
J Virol; 1991 Apr; 65(4):2056-65. PubMed ID: 1705995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
